SecSonar.com

Shattuck Labs, Inc. (STTK)

Shattuck Labs, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Shattuck Labs, Inc. (STTK) is a Biotechnology company based in US with a market capitalization of $285M. Revenue declined 82.5% year-over-year and free cash flow was negative at -$40M. This page tracks STTK's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 44 employees · IPO Oct 9, 2020

Valuation

Valuation & price

$6.26 · as of May 17, 2026 · -20.6% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

3.46

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$7.75$4.24$0.74Jul 25Dec 25Jul 26Jul 7, 25$0.77Jul 9, 25$0.82Jul 11, 25$0.82Jul 15, 25$0.79Jul 17, 25$0.74Jul 21, 25$0.77Jul 23, 25$0.82Jul 25, 25$0.85Jul 29, 25$0.84Jul 31, 25$0.76Aug 4, 25$0.74Aug 6, 25$0.82Aug 11, 25$0.74Aug 13, 25$0.81Aug 15, 25$1.00Aug 19, 25$1.03Aug 21, 25$0.89Aug 25, 25$0.99Aug 27, 25$1.00Aug 29, 25$0.98Sep 3, 25$1.28Sep 5, 25$1.55Sep 9, 25$2.01Sep 11, 25$1.98Sep 16, 25$2.14Sep 18, 25$2.23Sep 22, 25$2.45Sep 24, 25$2.35Sep 26, 25$2.28Sep 30, 25$2.39Oct 2, 25$2.37Oct 6, 25$2.59Oct 8, 25$2.39Oct 10, 25$1.84Oct 14, 25$1.87Oct 16, 25$1.80Oct 21, 25$1.92Oct 23, 25$1.85Oct 27, 25$2.06Oct 29, 25$1.95Oct 31, 25$1.92Nov 4, 25$1.93Nov 6, 25$1.96Nov 10, 25$1.89Nov 12, 25$1.92Nov 14, 25$1.88Nov 18, 25$2.01Nov 20, 25$1.93Nov 25, 25$2.01Nov 28, 25$2.10Dec 2, 25$2.48Dec 4, 25$2.97Dec 8, 25$3.01Dec 10, 25$3.23Dec 12, 25$3.10Dec 16, 25$2.94Dec 18, 25$2.96Dec 22, 25$3.14Dec 24, 25$3.28Dec 29, 25$3.50Jan 2, 26$3.71Jan 6, 26$3.98Jan 8, 26$4.64Jan 12, 26$4.59Jan 14, 26$4.73Jan 16, 26$4.64Jan 21, 26$4.44Jan 23, 26$4.15Jan 27, 26$4.02Jan 29, 26$4.07Feb 2, 26$3.85Feb 4, 26$3.85Feb 9, 26$3.97Feb 11, 26$4.09Feb 13, 26$3.86Feb 18, 26$4.01Feb 20, 26$4.01Feb 24, 26$4.28Feb 26, 26$4.04Mar 2, 26$4.00Mar 4, 26$4.73Mar 6, 26$5.99Mar 10, 26$5.96Mar 12, 26$6.13Mar 17, 26$5.95Mar 19, 26$6.10Mar 23, 26$6.12Mar 25, 26$6.37Mar 27, 26$6.02Mar 31, 26$6.43Apr 2, 26$6.42Apr 7, 26$6.78Apr 9, 26$7.40Apr 13, 26$6.77Apr 15, 26$7.17Apr 17, 26$7.53Apr 22, 26$7.75Apr 24, 26$7.74Apr 28, 26$7.53Apr 30, 26$7.15May 4, 26$6.92May 6, 26$6.68May 8, 26$6.85May 12, 26$6.62May 14, 26$6.67May 18, 26$5.97May 20, 26$6.17May 22, 26$6.10May 28, 26$5.97Jun 1, 26$5.65Jun 3, 26$4.75Jun 5, 26$4.58Jun 9, 26$4.27Jun 11, 26$4.18Jun 15, 26$4.63Jun 17, 26$4.74Jun 22, 26$5.24Jun 24, 26$6.01Jun 26, 26$6.44Jul 2, 26$7.05
$0.7352-week range$7.88
Loading valuation history…

Fundamentals

Key fundamentals

$285M

Market cap

-82.5%

Revenue growth (YoY)

100.0%

Gross margin

-$40M

Free cash flow (USD)

-$76.5M

Net debt

Net cash position

37.1%

Share dilution

1/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2018 → 2025

FY 2018$22.4MFY 2019$9.9MFY 2020$9.9MFY 2021$30.0MFY 2022$652.0KFY 2023$1.7MFY 2024$5.7MFY 2025$1.0M
$22.4M$1M

Free cash flow by year

2018 → 2025

FY 2018$-8.1MFY 2019$-21.4MFY 2020$-34.4MFY 2021$-65.0MFY 2022$-106.1MFY 2023$-81.6MFY 2024$-60.6MFY 2025$-40.0M
-$8.1M-$40M

Gross margin by year

2021 → 2025

FY 202195.4%FY 2022100.0%FY 2023-143.9%FY 2024100.0%FY 2025100.0%
95.4%100.0%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

2

Insider sells · 90 days

Earnings

Last report: 10-Q filed May 7, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • Insider sellInsider Sell $210K · 10b5-1 PlanPandite Arundathy N. · Chief Medical Officer · $210.3KJul 2, 2026Filing
  • Insider sellInsider Sell $166K · 10b5-1 PlanShukla Abhinav A. · Chief Technical Officer · $166.1KJul 2, 2026Filing
  • 8-K eventStock OfferingJun 11, 2026Filing
  • 8-K eventPhase 1 Clinical Trial ResultsJun 9, 2026Filing
  • 8-K eventEquity Incentive Plan AmendedJun 2, 2026Filing
  • 8-K eventEarnings ReleaseMay 7, 2026Filing
  • Quarterly report10-Q FiledMay 7, 2026Filing

Questions

Frequently asked questions

What is Shattuck Labs, Inc.'s market cap?

Shattuck Labs, Inc. (STTK) has a market capitalization of $285M.

What is STTK's P/E ratio?

A meaningful P/E ratio is not available for STTK — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

What is STTK's price-to-book (P/B) ratio?

STTK trades at 3.46 times book value per share.

Are insiders buying STTK stock?

SEC Form 4 filings show no open-market insider buys at Shattuck Labs, Inc. in the last 90 days (2 sells).

Same arena

Related companies in Biotechnology

FENC

Fennec Pharmaceuticals Inc.

$284.4M

ACIU

AC Immune S.A.

$281.4M

AKBA

Akebia Therapeutics, Inc.

$280.3M

ZNTL

Zentalis Pharmaceuticals, Inc.

$290.7M

TRDA

Entrada Therapeutics, Inc.

$272.5M

ALT

Altimmune, Inc.

$270.9M

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.